Mesa Laboratories Inc (MLAB)
Days of sales outstanding (DSO)
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | 5.74 | 6.15 | 5.68 | 6.29 | 5.54 | 5.91 | 5.88 | 6.16 | 5.15 | 5.25 | 5.33 | 4.78 | 4.47 | 4.38 | 6.31 | 6.75 | 5.63 | 6.38 | 6.88 | 6.77 | |
DSO | days | 63.57 | 59.33 | 64.30 | 58.03 | 65.94 | 61.77 | 62.07 | 59.25 | 70.89 | 69.59 | 68.50 | 76.41 | 81.63 | 83.29 | 57.82 | 54.07 | 64.82 | 57.23 | 53.07 | 53.93 |
March 31, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.74
= 63.57
The Days Sales Outstanding (DSO) for Mesa Laboratories Inc provides insight into the company's efficiency in collecting receivables from its customers. As of the most recent data available, the DSO trend has exhibited fluctuation over the past few years.
From June 30, 2020, to September 30, 2021, the DSO remained relatively stable, fluctuating within a range of approximately 50 to 60 days. However, there was a noticeable increase in DSO from December 31, 2021, reaching a peak of 83.29 days. This increase suggests that Mesa Laboratories may have experienced challenges in collecting payments from customers during this period.
Subsequently, there was a slight decrease in DSO by March 31, 2022, and the trend continued to fluctuate between 60 to 80 days until September 30, 2023. From there, the DSO started to show a decreasing trend, indicating potential improvements in the company's receivables collection efficiency.
Overall, Mesa Laboratories Inc should continue to monitor its DSO closely to ensure efficient management of its accounts receivable and timely collection of payments from customers. A lower DSO indicates a quicker turnover of accounts receivable, which is generally favorable for the company's cash flow and liquidity position.
Peer comparison
Mar 31, 2025